Insulin-like Growth Factor-I Stimulates Acromegaly-like Specific Mandibular Enlargement in Rats

Abstract

To help us investigate the time course of mandibular enlargement in acromegaly or acrogiantism to determine the most suitable period for occlusal treatment in this disease, our aim was to develop a rat model of acromegaly (acrogiantism). In this study, prominent mandibular enlargement was induced by continuous subcutaneous infusion of human recombinant insulin-like growth factor-I (IGF-I) (640 µg/day) in 10-week-old male rats for 4 weeks (n = 6); the control sham-operated group was injected with saline alone (n = 6). Circulating human IGF-I was clearly detectable in the IGF-I group during the four-week administration period, while endogenous rat IGF-I levels decreased. Total IGF-I (human + rat) increased significantly during administration, returning to control levels afterwards. The length of every bone examined (mandible, maxilla, and femur) showed a significant increase compared to control rats, especially the mandible. Although the mandible did not continue to grow after discontinuation of IGF-I administration, it did not return to control size, unlike the maxilla and femur, and disharmonious jaw size (between maxilla and mandible) persisted even after circulating IGF-I levels normalized. These findings in our rat model suggest that mandibular occlusal treatment should only be considered for acromegalic (acrogiantic) patients after serum IGF-I levels have normalized and bone growth has ceased.

Key words

Acromegaly - Rat Model - IGF-I - Mandibular enlargement - Bone growth

References

• 1 Hinds E C. Noninflammatory bone disease.  J Oral Surg. 1970;  28 27-38
• 2 Anton H C. Hand measurements in acromegaly.  Clin Radiol. 1972;  23 445-450
• 3 Kunzler A, Farmand M. Typical changes in the viscerocranium in acromegaly.  J Cranio-Max-Fac Surg. 1991;  19 332-340
• 4 Takakura M, Kuroda T. Morphologic analysis of dentofacial structure in patients with acromegaly.  Int J Adult Orthod Orthognath Surg. 1998;  13 277-288
• 5 Converse J M, Baker D C. Surgical correction of the facial deformities of acromegaly.  Ann Plast Surg. 1978;  1 612-616
• 6 Jackson I T, Meland N B, Keller E E, Satber A H. Surgical correction of the acromegalic face: a one stage procedure with team approach.  J Cranio-Max-Fac Surg. 1989;  17 2-8
• 7 Schoenle E, Zapt J, Humbel R E, Froesch E R. Insulin-like growth factor-I stimulates growth in hypophysectomized rats.  Nature. 1982;  296 252-253
• 8 Zhao G, Monier-Fauger M C, Langub M C, Geng Z, Nakayama T, Pike J W, Chernausek S D, Rosen C J, Donahue L R, Malluche H H, Eagin J A, Clemens T L. Targeted overexpression of insulin-like growth factor I to osteoblast of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.  Endocrinology. 2000;  141 2678-2682
• 9 Phillip D KL, Bonita K B, Frances L, Elain Y WK, Raymond L H. A homologous radioimmunoassey for rat insulin-like growth factor-I (IGF-I): implications for studies of human IGF-I physiology.  J Clin Endocrinol Metab. 1996;  81 2002-2005
• 10 Andreassen T T, Jørgensen P H, Flyvbjerg A, Ørskov H, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats.  J Bone Miner Res. 1995;  10 1507-1067
• 11 Andreassen T T, Melsen F, Oxlund H. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats.  J Bone Miner Res. 1996;  11 1094-1102
• 12 Morimoto I, Kai K, Okada Y, Okimoto N, Uriu K, Akino K, Yamashita S, Nakamura T, Eto S. Skeletal changes in rats bearing mammosomatotrophic pituitary tumors: a model of acromegaly with gonadal dysfunction.  Bone. 2000;  26 255-261
• 13 Giustina A, Barkan A, Casanueva F F, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Werder K, Melmed S. Criteria for cure of acromegaly: a consensus statement.  J Clin Endocrinol Metab. 2000;  85 526-529
• 14 Wronski T J, Dann L M, Scott K S, Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton.  Calcif Tissue Int. 1989;  45 360-366
• 15 Clemmons D R, van Wyk J J, Ridgway E C, Kliman B, Kjellberg R N, Underwood L E. Evaluation of acromegaly by radioimmunoassay of somatomedin-C.  N Engl J Med. 1979;  301 1138-1142
• 16 Rie M, Kuhn J M, Bricaire H, Luton J P. Evaluation of treated acromegalic patients with normal growth hormone levels during oral glucose load.  Acta Endocrinol. 1984;  107 1-8
• 17 Melmed S. Acromegaly.  N Engl J Med. 1990;  322 966-977
• 18 Bermann M, Jaff C A, Tsai W, Demott-Friberg R, Barkan A L. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I.  J Clin Invest. 1994;  94 138-145
• 19 Ikeda H, Jokura H, Yoshimoto T. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma.  J Neurosurg. 2001;  95 285-291
• 20 Tominaga A, Arita K, Kurisu K, Uozumi T, Migita K, Eguchi K, Iida K, Kawamoto H, Mizoue T. Effect of successful adenomectomy on body composition in acromegaly.  Endocr J. 1998;  45 335-342
• 21 Igarashi K, Mitani H, Adachi H, Shinoda H. Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats.  Am J Orthod Dentofac Orthop. 1994;  106 279-289
• 22 Hayashi K, Igarashi K, Miyoshi K, Shinoda H, Mitani H. Involvement of nitric oxide in orthodontic tooth movement in rats.  Am J Orthod Dentofac Orthop. 2002;  122 306-309
• 23 Malpe R, Baylink D J, Linkhart T A, Wergedal J E, Mohan S. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cell are skeletal site-dependent.  J Bone Miner Res. 1997;  12 423-430
• 24 Chalk W O. Partial dislocation of the lower jaw from an enlarged tongue.  Transaction of the Pathological Society, London. 1856;  8 305-308
• 25 Benda C. Akromegalie.  Deutsche Klinik am Eingange Des Zwanzigsten Jahrhunderts. 1902;  3 261